Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Like this? Share it with your network

Share

Industry analysis pharma

on

  • 5,396 views

 

Statistics

Views

Total Views
5,396
Views on SlideShare
5,396
Embed Views
0

Actions

Likes
0
Downloads
293
Comments
1

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
  • goode
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Indian Drug Manufacturers' Association (IDMA)OPPI - Organisation of Pharmaceutical Producers of IndiaBulk Drug Manufacturers AssociationAssociation of Pharmaceutical Teachers of IndiaIndian Pharmaceutical AssociationConfederation of Indian Pharmaceutical Industry (SSI)

Industry analysis pharma Presentation Transcript

  • 1. Industry Analysis: Pharma
    “The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent.”Richard Gerster
    Presented By:-
    NeerajGoswami
    PrernaAgarwal
    OjaswiKatiyar
  • 2. Contents
    1) Overview of Indian pharma.
    2) Evolution of Indian Pharma.
    3) Major players.
    4) Drug Trial.
    5) Medical tourism.
    6) Moving up to the value chain.
    7) Pharmaceutical-association in India.
    8) Future scenario.
    9) Pharma in news.
  • 3. Indian Pharmaceutical Evolution
    Phase V
    Innovation and Research
    • New IP law
    • 4. Discovery Research
    • 5. Convergence
    Phase IV
    Growth Phase
    • Rapid expansion of domestic market
    • 6. International market development
    • 7. Research orientation
    Phase III Development Phase
    • Process development
    • 8. Production infrastructure creation
    • 9. Export initiatives
    Phase II
    Government Control
    • Indian Patent Act –1970
    • 10. Drug prices capped
    • 11. Local companies begin to make an impact
    Phase I
    Early Years
    • Market share domination by foreign companies
    • 12. Relative absence of organized Indian companies
    1970
    1980
    1990
    2000
    2010
  • 13.
  • 14. Drug Trial
    Phase-1
    Phase-2
    Phase-3
    Phase-4
    Benefits:-
    Play an active role in their own health care.
    Gain access to new research treatments before they are widely available.
    Obtain expert medical care at leading health care facilities during the trial.
    Help others by contributing to medical research.
    Risks:-
    There may be unpleasant, serious or even life-threatening side effects to experimental treatment.
    The experimental treatment may not be effective for the participant.
  • 15. Medical Tourism
    Cheaper medical and relaxation needs.
    Excellent infrastructure and technology in which is in par with those in USA, UK and Europe.
    Some treatments which are best in India are:-
    Eye Care
    Dental Care
    IVF Treatment
    Heart Surgery & Heart Care
    Health Check Up
    Cosmetic Treatment
    Orthopedic Surgery
  • 16. Moving up the Value Chain
    VALUE
    Innovative Products
    Specialty Products
    Generic exports to developed countries
    Generic exports to under-developed & developing countries
    API Exports
    TIME
  • 17. Pharmaceutical Associations In India
    IDMA CIPI-SSI
    OPPI IPA
    BDMA APTI
  • 18. Indian Pharma Industry – Future Scenario
    The Indian pharma industry is still trying to come to terms with the new patent regime.
    Over the next 5 years, will continue to grow by at least twice the rate of global growth.
    Retail segment will be the fastest growing segment.
    There will be a significant increase in the clinical trials and diagnostics outsourcing.
    A significant window of opportunity will be available expiring patents.
  • 19. Pharma in News
    August 20, 2008: 49 babies die at leading hospitals under drug trail process.
    Fight between Ranbaxy and Pfizer.(Lipitor)
    H1N1 vaccination available in Indian Pharmaceutical market. (Nasovac)
    Aurobindo pharma and Astra-Zeneca to jointly supply solid dosage in emerging market.
  • 20. Biblograpahy
    www.pharmainfo.net
    www.fairdrugs.org
    www.ipapharma.org
    www.pharmabiz.com
    www.pharmaceutical-drug-manufacturers.com
    www.medindia.net
  • 21. Thankyou….!
    Any queries ?